Carey Danis & Lowe Actos lawyers were optimistic last week when plaintiff Jack Cooper received a compensatory award in the amount of $6.5 million. However, it appears that California Superior…
Read More
A California jury recently awarded a compensatory package of $6.5 million to a plaintiff in an Actos bladder cancer lawsuit. The case, Cooper v. Takeda, was heard over a two…
Read More
Parties involved in the Actos multi-district litigation (MDL) in the U.S. District Court for the Western District of Louisiana met for a Status Conference on January 24, 2013. The MDL…
Read More
An Actos Multi-District Litigation (MDL) has been consolidated in Louisiana as of December 2011. The Actos MDL is being heard by U.S. District Judge Doherty in the U.S. District Court…
Read More
The first trial in more than 3,000 Actos lawsuits filed in the U.S. is currently being heard in a Los Angeles court. Lawyers at Carey Danis & Lowe reported last…
Read More
Actos is a type 2 diabetes medication intended to improve glucose and blood sugar control. The active ingredient in the drug is a generic medication called pioglitazone hydrochloride, and the…
Read More
Actos is a drug developed by Takeda Pharmaceuticals, and is prescribed to patients with type 2 diabetes. The drug Actos has been closely linked with bladder cancer. Plaintiffs in Actos…
Read More
Submit Your Claim The European Medicines Agency made an effort to provide more detail on its conclusion regarding the safety of drugs containing pioglitazone, including the diabetes drug Actos. The…
Read More